AB
THRX

Amalgamated Bank’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Amalgamated Bank’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,612
Closed -$7K – 2991
2023
Q4 		$7K Sell
1,612
-184
-10% -$561 ﹤0.01% 2920
2023
Q3 		$5K Hold
1,796
– – ﹤0.01% 2977
2023
Q2 		$17K Hold
1,796
– – ﹤0.01% 2827
2023
Q1 		$16K Sell
1,796
-105
-6% -$1.03K ﹤0.01% 2728
2022
Q4 		$9K Hold
1,901
– – ﹤0.01% 2893
2022
Q3 		$11K Hold
1,901
– – ﹤0.01% 2934
2022
Q2 		$11K Buy
1,901
+231
+14% +$1.91K ﹤0.01% 2983
2022
Q1 		$19K Buy
+1,670
New +$17.9K ﹤0.01% 2828

Amalgamated Bank's THRX Position: Q1 2024 in Review

Amalgamated Bank sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 1,612 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in THRX in Q1 2022 and held it in 8 quarters. The position peaked at $19K in Q1 2022. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • Amalgamated Bank reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Amalgamated Bank sold 1,612 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $7K.
  • Amalgamated Bank first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $19K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Amalgamated Bank's 13F filing for Q1 2024, filed 23 Apr 2024.